These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1405317)

  • 1. Extrarenal cytokines modulate the glomerular response to IgA immune complexes.
    Montinaro V; Hevey K; Aventaggiato L; Fadden K; Esparza A; Chen A; Finbloom DS; Rifai A
    Kidney Int; 1992 Aug; 42(2):341-53. PubMed ID: 1405317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen as mediator of glomerular injury in experimental IgA nephropathy.
    Montinaro V; Esparza AR; Cavallo T; Rifai A
    Lab Invest; 1991 Apr; 64(4):508-19. PubMed ID: 2016857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental IgA nephropathy. Enhanced deposition of glomerular IgA immune complex in proteinuric states.
    Chen A; Ding SL; Sheu LF; Song YB; Shieh SD; Shaio MF; Chou WY; Ho YS
    Lab Invest; 1994 May; 70(5):639-47. PubMed ID: 8196360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endogenous immune response modulates the course of IgA-immune complex mediated nephropathy.
    Chao TK; Rifai A; Ka SM; Yang SM; Shui HA; Lin YF; Sytwu HK; Lee WH; Kung JT; Chen A
    Kidney Int; 2006 Jul; 70(2):283-97. PubMed ID: 16738538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymolysis of glomerular immune deposits in vivo with dextranase/protease ameliorates proteinuria, hematuria, and mesangial proliferation in murine experimental IgA nephropathy.
    Gesualdo L; Ricanati S; Hassan MO; Emancipator SN; Lamm ME
    J Clin Invest; 1990 Sep; 86(3):715-22. PubMed ID: 2203821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-idiotype antibody directly interferes with glomerular IgA immune complex deposition.
    Chen A; Sheu LF; Shaio MF; Huang TH; Ding SL; Lee WH
    Nephron; 1998; 78(4):464-73. PubMed ID: 9578073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy.
    Chen A; Sheu LF; Ding SL; Lee WH
    Lab Invest; 1996 Apr; 74(4):737-46. PubMed ID: 8606484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation in experimental IgA nephropathy: an antigen-mediated process.
    Rifai A; Chen A; Imai H
    Kidney Int; 1987 Dec; 32(6):838-44. PubMed ID: 3430967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of mesangial complement in the hematuria of experimental IgA nephropathy.
    Emancipator SN; Ovary Z; Lamm ME
    Lab Invest; 1987 Sep; 57(3):269-76. PubMed ID: 3306149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular electron-dense deposits in childhood IgA nephropathy.
    Yoshikawa N; Ito H; Nakahara C; Yoshiara S; Yoshiya K; Matsuo T; Hasegawa O; Hazikano H; Okada S
    Virchows Arch A Pathol Anat Histopathol; 1985; 406(1):33-43. PubMed ID: 3158115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA nephropathy: immune mechanisms beyond IgA mesangial deposition.
    Rifai A
    Kidney Int; 2007 Aug; 72(3):239-41. PubMed ID: 17653232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of renal injury in a chronic model of IgA immune-complex-associated nephropathy.
    Montinaro V; Aventaggiato L; Cavallo T; Rifai A
    Nephrol Dial Transplant; 1995 Nov; 10(11):2035-42. PubMed ID: 8643164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of activated human mesangial cell proliferation by the natural product of Cordyceps sinensis (H1-A): an implication for treatment of IgA mesangial nephropathy.
    Lin CY; Ku FM; Kuo YC; Chen CF; Chen WP; Chen A; Shiao MS
    J Lab Clin Med; 1999 Jan; 133(1):55-63. PubMed ID: 10385482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [IgA nephropathy].
    Basta-Jovanović G
    Srp Arh Celok Lek; 2004; 132(1-2):41-3. PubMed ID: 15227965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic characterization of cytokine expression in patients with IgA nephropathy.
    Yano N; Endoh M; Nomoto Y; Sakai H; Fadden K; Rifai A
    J Clin Immunol; 1997 Sep; 17(5):396-403. PubMed ID: 9327339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental IgA nephropathy.
    Rifai A; Small PA; Teague PO; Ayoub EM
    J Exp Med; 1979 Nov; 150(5):1161-73. PubMed ID: 159331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA deposits might not influence the production of extracellular matrix in glomeruli of ddY mice, a spontaneous animal model for IgA nephropathy.
    Tsushima Y; Tomino Y; Shimizu M; Ohmuro H; Takeuchi K; Kuramoto T; Shirato I; Koide H
    Nephron; 1994; 66(1):81-6. PubMed ID: 7906404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular immune deposits in experimental IgA nephropathy. A continuum of circulating and in situ formed immune complexes.
    Chen A; Wong SS; Rifai A
    Am J Pathol; 1988 Jan; 130(1):216-22. PubMed ID: 3276211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial IgA protease removes IgA immune complexes from mouse glomeruli in vivo: potential therapy for IgA nephropathy.
    Lamm ME; Emancipator SN; Robinson JK; Yamashita M; Fujioka H; Qiu J; Plaut AG
    Am J Pathol; 2008 Jan; 172(1):31-6. PubMed ID: 18165266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.